Qsymia vs. Phentermine
See how Qsymia and Phentermine compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Qsymia combines phentermine with topiramate for FDA-approved long-term weight management, while phentermine alone is only approved for a few weeks of use.
Both drugs are Schedule IV controlled substances that suppress appetite, but Qsymia requires REMS pharmacy enrollment due to a birth defect risk.
Phentermine costs much less out of pocket than Qsymia, but Qsymia's dual mechanism is designed for more sustained weight loss over time.
Qsymia vs. Phentermine Drug Summary
Qsymia
Qsymia is a combination of phentermine, a stimulant appetite suppressant, and topiramate, an anticonvulsant that helps curb appetite and cravings. It is FDA-approved for chronic weight management in adults and in adolescents 12 and older with obesity or excess weight plus a related health condition. Qsymia is taken as one extended-release capsule daily, with the dose increased gradually over 12 to 16 weeks.
Phentermine
Phentermine is a stimulant appetite suppressant used on its own to jump-start weight loss. It is FDA-approved only for a few weeks of use in adults with obesity or excess weight plus a related risk factor, alongside diet and exercise. Phentermine is taken once daily as a tablet or capsule, usually at a fixed dose with no titration schedule.
Qsymia vs. Phentermine Side Effects
Qsymia
Phentermine
Qsymia vs. Phentermine Dosage
Qsymia
Phentermine
| STAGE | DOSE | WHEN |
| Starting dose | 3.75 mg/23 mg once daily | Days 1-14 |
| Maximum dose | 15 mg/92 mg once daily | Week 17 onward |
| Dose changes | 3 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 37.5 mg once daily | At the start |
| Maximum dose | 15 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Qsymia
| STAGE | DOSE | WHEN |
| Starting dose | 3.75 mg/23 mg once daily | Days 1-14 |
| Maximum dose | 15 mg/92 mg once daily | Week 17 onward |
| Dose changes | 3 increases | As tolerated |
Phentermine
| STAGE | DOSE | WHEN |
| Starting dose | 37.5 mg once daily | At the start |
| Maximum dose | 15 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Qsymia vs. Phentermine Indications
Qsymia
Qsymia is approved for chronic, ongoing weight management rather than a short course of treatment. It can be prescribed to adults with obesity, adults who are overweight with a related condition such as high blood pressure or type 2 diabetes, and adolescents 12 and older with obesity.
Adults with obesity (BMI 30 or higher)
Adults overweight with a weight-related condition
Adolescents 12 and older with obesity
Long-term, ongoing use
Phentermine
Phentermine is approved only as a short-term aid for weight loss, meant for a few weeks alongside diet, exercise, and behavior changes. It is prescribed for adults with obesity or for adults who are overweight with an added risk factor such as high blood pressure.
Adults with obesity (BMI 30 or higher)
Adults overweight with a risk factor (BMI 27+)
Short-term use only (a few weeks)
Adjunct to diet and exercise
Qsymia vs. Phentermine Pros and Cons
Qsymia
Qsymia's dual mechanism, combining an appetite suppressant with an anticonvulsant, is designed for sustained weight loss over months to years under ongoing medical supervision. Because of its risk of birth defects, it is only available through certified REMS-enrolled pharmacies, which adds an extra step for patients. This more involved regimen reflects its intended use for chronic, long-term treatment rather than a short course.
Pros
FDA-approved for long-term, chronic weight management
Approved for adolescents 12 and older
Dual mechanism may produce greater weight loss than phentermine alone
Simple once-daily dosing after titration
Cons
Requires REMS enrollment and certified pharmacy dispensing
Not safe in pregnancy; requires monthly pregnancy testing
More monitoring needed for mood, cognition, and heart rate
Costs roughly $200 to $350 per month without insurance, more than phentermine
Phentermine
Phentermine's single stimulant mechanism is meant for a short, defined course of treatment rather than ongoing use. It has decades of clinical history and a well-established safety profile, without the added anticonvulsant risks that come with Qsymia. Because it is not approved for long-term therapy, patients typically stop or switch to another option once the initial period ends.
Pros
Long history of clinical use since 1959
No REMS program or specialty pharmacy required
Simpler dosing without a multi-week titration schedule
Costs roughly $15 to $75 per month without insurance, far less than Qsymia
Cons
Approved for only a few weeks of use, not long-term treatment
Lacks the added appetite-suppressing mechanism of topiramate
Cardiovascular stimulant effects like rapid heartbeat may be more noticeable
May require switching to another therapy once the short course ends
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.